Myeloid phenotypes in severe COVID-19 predict secondary infection and mortality: a pilot study.

Clémence MaraisCaroline ClaudeNada SemaanRamy CharbelSimon BarreaultBrendan TravertJean-Eudes PiloquetZoé DemaillyLuc MorinZied MerchaouiJean-Louis TeboulPhilippe DurandJordi MiatelloPierre Tissèresnull null

Published in: Annals of intensive care (2021)

Myeloid phenotypes of critically ill COVID-19 patients may be associated with development of secondary infection, 28- and 60-day mortality.

Keyphrases

sars cov
cardiovascular events
dendritic cells
coronavirus disease
bone marrow
acute myeloid leukemia
risk factors
early onset
type diabetes
coronary artery disease
immune response
drug induced